940 related articles for article (PubMed ID: 28250648)
1. The Influence of Pluronic F68 and F127 Nanocarrier on Physicochemical Properties,
Shaarani S; Hamid SS; Mohd Kaus NH
Pharmacognosy Res; 2017; 9(1):12-20. PubMed ID: 28250648
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticles and Its Cytotoxicity Effects in Tamoxifen-Resistant Breast Cancer Cells.
Ahmad R; Kaus NHM; Hamid S
Adv Exp Med Biol; 2020; 1292():65-82. PubMed ID: 30560443
[TBL] [Abstract][Full Text] [Related]
3. Formulation, Characterization and Cytotoxicity Effects of Novel Thymoquinone-PLGA-PF68 Nanoparticles.
Noor NS; Kaus NHM; Szewczuk MR; Hamid SBS
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502328
[TBL] [Abstract][Full Text] [Related]
4. Enhanced in vitro cytotoxicity and anti-tumor activity of vorinostat-loaded pluronic micelles with prolonged release and reduced hepatic and renal toxicities.
Mohamed EA; Abu Hashim II; Yusif RM; Suddek GM; Shaaban AAA; Badria FAE
Eur J Pharm Sci; 2017 Jan; 96():232-242. PubMed ID: 27667706
[TBL] [Abstract][Full Text] [Related]
5. Delivery of phytochemical thymoquinone using molecular micelle modified poly(D, L lactide-co-glycolide) (PLGA) nanoparticles.
Ganea GM; Fakayode SO; Losso JN; van Nostrum CF; Sabliov CM; Warner IM
Nanotechnology; 2010 Jul; 21(28):285104. PubMed ID: 20585163
[TBL] [Abstract][Full Text] [Related]
6. Development of a Thymoquinone Polymeric Anticancer Nanomedicine through Optimization of Polymer Molecular Weight and Nanoparticle Architecture.
Sunoqrot S; Alfaraj M; Hammad AM; Kasabri V; Shalabi D; Deeb AA; Hasan Ibrahim L; Shnewer K; Yousef I
Pharmaceutics; 2020 Aug; 12(9):. PubMed ID: 32867015
[TBL] [Abstract][Full Text] [Related]
7. Formulation, Cellular Uptake and Cytotoxicity of Thymoquinone-Loaded PLGA Nanoparticles in Malignant Melanoma Cancer Cells.
Ibrahim WN; Muizzuddin Bin Mohd Rosli L; Doolaanea AA
Int J Nanomedicine; 2020; 15():8059-8074. PubMed ID: 33116518
[TBL] [Abstract][Full Text] [Related]
8. Encapsulation of curcumin in Pluronic block copolymer micelles for drug delivery applications.
Sahu A; Kasoju N; Goswami P; Bora U
J Biomater Appl; 2011 Feb; 25(6):619-39. PubMed ID: 20207782
[TBL] [Abstract][Full Text] [Related]
9. The comparison of anticancer activity of thymoquinone and nanothymoquinone on human breast adenocarcinoma.
Dehghani H; Hashemi M; Entezari M; Mohsenifar A
Iran J Pharm Res; 2015; 14(2):539-46. PubMed ID: 25901162
[TBL] [Abstract][Full Text] [Related]
10. Pluronic micelles encapsulated curcumin manifests apoptotic cell death and inhibits pro-inflammatory cytokines in human breast adenocarcinoma cells.
Vaidya FU; Sharma R; Shaikh S; Ray D; Aswal VK; Pathak C
Cancer Rep (Hoboken); 2019 Feb; 2(1):e1133. PubMed ID: 32721127
[TBL] [Abstract][Full Text] [Related]
11. Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential.
Ravindran J; Nair HB; Sung B; Prasad S; Tekmal RR; Aggarwal BB
Biochem Pharmacol; 2010 Jun; 79(11):1640-7. PubMed ID: 20105430
[TBL] [Abstract][Full Text] [Related]
12. Self-Assemble Amphiphilic PEO-PPO-PEO Tri-Block Co-Polymeric Methotrexate Nanomicelles to Combat MCF7 Cancer Cells.
Mishra MK; Gupta J; Gupta R
Curr Drug Deliv; 2021; 18(6):794-804. PubMed ID: 32778025
[TBL] [Abstract][Full Text] [Related]
13. Thymoquinone-Loaded Soluplus
Bergonzi MC; Vasarri M; Marroncini G; Barletta E; Degl'Innocenti D
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066549
[TBL] [Abstract][Full Text] [Related]
14. Coencapsulation of Gemcitabine and Thymoquinone in Citrem-Phosphatidylcholine Hexosome Nanocarriers Improves In Vitro Cellular Uptake in Breast Cancer Cells.
Loo YS; Zahid NI; Madheswaran T; Ikeno S; Nurdin A; Mat Azmi ID
Mol Pharm; 2023 Sep; 20(9):4611-4628. PubMed ID: 37587099
[TBL] [Abstract][Full Text] [Related]
15. Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization.
Mehanna MM; Sarieddine R; Alwattar JK; Chouaib R; Gali-Muhtasib H
Int J Nanomedicine; 2020; 15():9557-9570. PubMed ID: 33293807
[TBL] [Abstract][Full Text] [Related]
16. Synergic Activity Against MCF-7 Breast Cancer Cell Growth of Nanocurcumin-Encapsulated and Cisplatin-Complexed Nanogels.
Nguyen NT; Nguyen NNT; Tran NTN; Le PN; Nguyen TBT; Nguyen NH; Bach LG; Doan VN; Tran HLB; Le VT; Tran NQ
Molecules; 2018 Dec; 23(12):. PubMed ID: 30567316
[TBL] [Abstract][Full Text] [Related]
17. PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a.
Bhattacharya S; Ahir M; Patra P; Mukherjee S; Ghosh S; Mazumdar M; Chattopadhyay S; Das T; Chattopadhyay D; Adhikary A
Biomaterials; 2015 May; 51():91-107. PubMed ID: 25771001
[TBL] [Abstract][Full Text] [Related]
18. Assessing the viability of Soluplus® self-assembled nanocolloids for sustained delivery of highly hydrophobic lapatinib (anticancer agent): Optimisation and in-vitro characterisation.
Bonde GV; Ajmal G; Yadav SK; Mittal P; Singh J; Bakde BV; Mishra B
Colloids Surf B Biointerfaces; 2020 Jan; 185():110611. PubMed ID: 31704609
[TBL] [Abstract][Full Text] [Related]
19. Acute and subacute toxicity profiles of thymoquinone-loaded nanostructured lipid carrier in BALB/c mice.
Ong YS; Saiful Yazan L; Ng WK; Noordin MM; Sapuan S; Foo JB; Tor YS
Int J Nanomedicine; 2016; 11():5905-5915. PubMed ID: 27877037
[TBL] [Abstract][Full Text] [Related]
20. Chrysin-loaded folate conjugated PF127-F68 mixed micelles with enhanced oral bioavailability and anticancer activity against human breast cancer cells.
Baidya D; Kushwaha J; Mahadik K; Patil S
Drug Dev Ind Pharm; 2019 May; 45(5):852-860. PubMed ID: 30724621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
